FlightPlan for Embolization
System, Image Processing, Radiological. 510(k) K223490, from GE Medical Systems SCS (Buc, FR). Product code LLZ, class 2.
As of Nov 19, 2026, K223490 is an FDA 510(k) held by GE Medical Systems SCS, substantially equivalent on Mar 21, 2023 after 120 days, with no recalls tied to it in FDA's recall database.
- Review time: 120 days
- Recalls: 0
FlightPlan for Embolization is a post processing software package that helps the analysis of 3D X-ray angiography images. Its output is intended to be used by physicians as an adjunct means to help visualize vasculature during the planning phase of embolization procedures. FlightPlan for Embolization is not intended to be used during therapy delivery.
- FlightPlan for EmbolizationK193261 · GE Medical Systems SCS · Jan 24, 2020
- Innova IGS 5, Innova IGS 6, Discovery IGS 7, Discovery IGS 7 ORK181403 · GE Healthcare · Nov 2, 2018
- 3D Anatomical ModelK262132 · The Jacobs Institute · Nov 5, 2026
- LiLi DICOM Viewer (LiLi )K260454 · Elevate Imaging, Inc. · Nov 4, 2026
- Vitrea Advanced Visualization, Version 7.16K263648 · Canon Medical Informatics, Inc. · Oct 29, 2026
- MIM – KineticIDK261763 · Mim Software, Inc. · Oct 26, 2026
- PV-iCurve ProK261531 · Perception Vision Medical Technology Co., Ltd. · Oct 21, 2026
- Eden PACSK261788 · Higia., Inc. d/b/a Eden · Oct 21, 2026
- Syngo Carbon Space (VA4)K263048 · Siemens Healthineers AG · Sep 29, 2026
- Syneris PACS v.1.0.1.0K261874 · Syneris · Sep 23, 2026
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 21, 2022
- Review panel
- Radiology
- Regulation
- 21 CFR 892.2050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files